Former Chief Medical Officer · KYNTRA BIO, INC. (FGEN)

Deyaa Adib

FY2024 is the first fiscal year CompBrief holds for Deyaa Adib as a named executive officer of KYNTRA BIO; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$1,327,085

Salary $528,000Stock awards $102,600Bonus $150,000

2nd of 5 named executive officers at Kyntra BIO by FY2024 total.

5 named officers on file for KYNTRA BIO, FY2024

Deyaa Adib’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 2 equity grants, each cited to its filing
  • FGEN’s disclosed peer group of 19 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how KYNTRA BIO’s whole pay program stands against its peers

  • KYNTRA BIO’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on FGEN→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 25, 2025 (DEF 14A).

Free

Get Deyaa Adib’s full pay file as a PDF — free

More than this page: up to 10 years of Deyaa’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Deyaa Adib compensation by year

KYNTRA BIO Summary Compensation Table · the one fiscal year held
In US dollars, as KYNTRA BIO reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2024
Salary$528,000
Bonus$150,000
Stock awards$102,600
Option awards$441,720
Non-equity incentive$0
Pension and deferred compensation$0
All other$104,765
Total$1,327,085

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: KYNTRA BIO, INC. DEF 14A filed April 25, 2025, accession 0000950170-25-058841, and prior-year filings. Open the filing on EDGAR.

How this page was built: the KYNTRA BIO, INC. filed document, accession 0000950170-25-058841. Every figure is read from that document and cited to the page and table it appears in. Filed April 25, 2025.

KYNTRA BIO’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Thane WettigChief Executive Officer$2,642,113
Deyaa Adib · this pageFormer Chief Medical Officer$1,327,085
Christine ChungSenior Vice President, China Operations$1,175,838
Juan GrahamFormer Chief Financial Officer$1,045,674
David DeLuciaChief Financial Officer$686,152

The full KYNTRA BIO compensation record

free company brief

This page is one person within KYNTRA BIO's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are KYNTRA BIO's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Deyaa Adib's compensation dossier · One-time report. No refunds.